| Literature DB >> 30146242 |
Jing Li1, Yaru Zhang2, Bruno Da Silva Sil Dos Santos3, Feng Wang4, Yuyong Ma5, Christian Perez5, Yanling Yang6, Junmin Peng6, Seth M Cohen5, Tsui-Fen Chou4, Stephen T Hilton7, Raymond J Deshaies8.
Abstract
The 26S proteasome is the major proteolytic machine for breaking down cytosolic and nuclear proteins in eukaryotes. Due to the lack of a suitable assay, it is difficult to measure routinely and quantitatively the breakdown of proteins by the 26S proteasome in vitro. In the present study, we developed an assay to monitor proteasome-mediated protein degradation. Using this assay, we discovered that <span class="Chemical">epidithiodiketopiperazine (ETPs) blocked the degradation of our model substrate in vitro. Further characterization revealed that ETPs inhibited proteasome function by targeting the essential proteasomal deubiquitinase Rpn11 (POH1/PSMD14). ETPs also inhibited other JAMM (JAB1/MPN/Mov34 metalloenzyme) proteases such as Csn5 and AMSH. An improved ETP with fewer non-specific effects, SOP11, stabilized a subset of proteasome substrates in cells, induced the unfolded protein response, and led to cell death. SOP11 represents a class of Rpn11 inhibitor and provides an alternative route to develop proteasome inhibitors.Entities:
Keywords: Capzimin; JAMM protease; POH1; PSMD14; Rpn11; epidithiodiketopiperazine; gliotoxin; proteasome; protein degradation; ubiquitin
Mesh:
Substances:
Year: 2018 PMID: 30146242 PMCID: PMC6309308 DOI: 10.1016/j.chembiol.2018.07.012
Source DB: PubMed Journal: Cell Chem Biol ISSN: 2451-9448 Impact factor: 8.116